CCND1 and neoplasm: In addition, the positive rate of cyclin D1 was significantly higher in tumor tissues of the P+ group (30.81% ± 6.33%), approximately 2.5 times that of the control group (11.69% ± 3.58%) (p < 0.05) (Figure 3).